Curaleaf (OTCMKTS:CURLF) Shares Gap Up – Here’s What Happened

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $2.7580, but opened at $3.07. Curaleaf shares last traded at $2.94, with a volume of 111,595 shares trading hands.

Analyst Ratings Changes

A number of research analysts have commented on CURLF shares. Canaccord Genuity Group upgraded Curaleaf to a “strong-buy” rating in a research note on Thursday, October 9th. Alliance Global Partners reissued a “buy” rating on shares of Curaleaf in a research report on Monday. ATB Capital upgraded shares of Curaleaf to an “outperform” rating in a research note on Tuesday, December 2nd. Finally, Atb Cap Markets raised Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 2nd. Two analysts have rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Strong Buy”.

Curaleaf Trading Up 6.6%

The firm’s 50-day simple moving average is $2.72 and its 200-day simple moving average is $2.27. The company has a quick ratio of 0.71, a current ratio of 1.47 and a debt-to-equity ratio of 0.96. The firm has a market capitalization of $1.99 billion, a P/E ratio of -9.19 and a beta of 0.77.

Curaleaf (OTCMKTS:CURLF) last issued its earnings results on Wednesday, November 5th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative return on equity of 15.57% and a negative net margin of 19.50%. Analysts anticipate that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.